3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
15
Small Cell Lung Carcinoma
10
Carcinoma, Hepatocellular
9
Lung Neoplasms
8
Colorectal Neoplasms
7
Neoplasms
6
Prostatic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Renal Cell
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Sarcoma
3
Neoplasm Metastasis
3
Melanoma
3
Small Cell Lung Cancer Extensive Stage
2
Ovarian Neoplasms
2
Mesothelioma, Malignant
2
Liver Neoplasms
2
Extensive Stage Lung Small Cell Carcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Interventions
Gemcitabine
8
durvalumab
7
Cisplatin
7
Oxaliplatin
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Specimen Handling
5
Fluorouracil
5
Biopsy
5
Paclitaxel
4
Folfox protocol
4
Taxes
3
Irinotecan
3
pemigatinib
2
pembrolizumab
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Platinum
2
Nivolumab
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Carboplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tremelimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
atezolizumab
×
30 days
×
Clear all
No trials found.